Postmortem Study of Organ-Specific Toxicity in Glioblastoma Patients Treated with a Combination of Temozolomide, Irinotecan and Bevacizumab
Journal of Neuro-Oncology(2022)
Key words
Autopsy,Postmortem,End-organ toxicity,Chemotherapy,Temozolomide,Irinotecan,Bevacizumab,Glioblastoma (GBM),Glioma,Myelosuppression,Brain metastasis
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined